New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Niagen Bioscience Inc. (NASDAQ:NAGE) saw its stock rise 2% after securing an exclusive global commercial license from Norway’s Haukeland University Hospital to develop its nicotinamide riboside ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

A study links living near golf courses to higher Parkinson's risk, with strongest association found in those one to three ...

A breakthrough brain scan shows Parkinson’s drugs can misfire in the brain, helping some patients less than others. The fix?

These findings highlight the significance of rearing behavior and behavioral lateralization as potential behavioral markers ...

Earwax tests could help with early Parkinson’s detection, Chinese researchers discover, offering hope for improved diagnosis ...

Parkinson’s disease, the second most common neurodegenerative disorder globally, is often associated with vocal impairments, ...

The study indicates that pesticides and poorer water quality could be the cause of higher rates of the disease.